Lithium-induced uremia in rats - a new model of chronic renal failure.
Three groups of new-born rats were studied: Group Li/Li treated with Li for 16 weeks, group Li/C treated for 8 weeks followed by 8 weeks without Li, and Group C/C 16 weeks old controls. Both Li-treated groups showed severe reduction of renal function, particularly group Li/Li, where the mean GFR was reduced by 80%. Plasma urea, creatinine, and osmolality were increased, blood hemoglobin and hematocrit were reduced, whereas plasma Na, K, and standard bicarbonate were unchanged. Na clearance was maintained and fractional Na excretion thus increased. Fractional Li excretion was also increased, indicating inhibition of proximal tubular salt and water reabsorption. Renal concentrating ability was markedly reduced. When Li was withdrawn, plasma urea levels remained unchanged or continued to rise, and the concentrating defect persisted. The results demonstrate that Li administration to new-born rats causes irreversible chronic renal failure which may progress even in the absence of Li. This model of chronic renal failure has several characteristics in common with chronic renal failure in humans.
D000818:Animals; D003404:Creatinine / Q000097:blood; D004195:Disease Models, Animal; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D007671:Kidney Concentrating Ability / Q000187:drug effects; D007676:Kidney Failure, Chronic / Q000139:chemically induced / Q000503:physiopathology*; D008094:Lithium / Q000097:blood; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains / Q000502:physiology; D012964:Sodium / Q000097:blood; D014508:Urea / Q000097:blood; D014511:Uremia / Q000139:chemically induced*
D014508:Urea; D008094:Lithium; D012964:Sodium; D003404:Creatinine